1Yu GP,Li JC,Branovan D,et al.Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, andend Results race / ethnicity groups. Thyroid, 2010,20(5):465-473.
2Tuttle RM,Ball DW,Byrd D. Thyroid carcinoma[J].J Natl Compr C anc Netw,2010.1228-1274.
3D'Avanzo B,LaVecchia C,Franceschi S. History of thyroid diseases and subsequent thyroid cancer risk[J].Cancer Epidemiol Biomakers Prev,1995,(3):193-199.
5Can AS,Peker K. Comparison of palpation-versus ultrasound-guided fine-needle aspiration biopsies in the evaluation of thyroid nodules[J].BMC Res Notes,2008.12.
6O'Malley ME,Weir MM,Hahn PF. US-guided fineneedle aspiration biopsy of thyroid nodules:adequacy of cytologic material and procedure time with and without immediate cytologic analysis[J].{H}RADIOLOGY,2002,(2):383-387.
7Siddiqui MT,Greene KL,Clark DP. Human telomerase reverse transcriptase expression in Diff-Quikstained FNA samples from thyroid nodules[J].Diagn Mol Patho1,2001,(2):123-129.
8Finley DJ,Zhu B,Barden CB. Discrimination of benign and malignant thyroid nodules by molecular profiling[J].{H}ANNALS OF SURGERY,2004,(3):425-437.
9Mazzaferri EL. NCCN Thyroid Cancer Practice Guidelines[J].Oncology-Huntington,1999,(11):391-442.
